Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies.
Tezuka T, Takahata K, Seki M, Tabuchi H, Momota Y, Shiraiwa M, Suzuki N, Morimoto A, Nakahara T, Iwabuchi Y, Miura E, Yamamoto Y, Sano Y, Funaki K, Yamagata B, Ueda R, Yoshizaki T, Mashima K, Shibata M, Oyama M, Okada K, Kubota M, Okita H, Takao M, Jinzaki M, Nakahara J, Mimura M, Ito D. Tezuka T, et al. Among authors: yamamoto y. Brain Commun. 2021 Aug 24;3(4):fcab190. doi: 10.1093/braincomms/fcab190. eCollection 2021. Brain Commun. 2021. PMID: 34632382 Free PMC article.
Findings of 18 F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sample.
Bun S, Moriguchi S, Tezuka T, Sato Y, Takahata K, Seki M, Nakajima S, Yamamoto Y, Sano Y, Suzuki N, Morimoto A, Ueda R, Tabuchi H, Ito D, Mimura M. Bun S, et al. Among authors: yamamoto y. Neuropsychopharmacol Rep. 2022 Dec;42(4):437-448. doi: 10.1002/npr2.12281. Epub 2022 Jul 17. Neuropsychopharmacol Rep. 2022. PMID: 35843629 Free PMC article.
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.
Shimohama S, Tezuka T, Takahata K, Bun S, Tabuchi H, Seki M, Momota Y, Suzuki N, Morimoto A, Iwabuchi Y, Kubota M, Yamamoto Y, Sano Y, Shikimoto R, Funaki K, Mimura Y, Nishimoto Y, Ueda R, Jinzaki M, Nakahara J, Mimura M, Ito D. Shimohama S, et al. Among authors: yamamoto y. Neurology. 2023 Jan 17;100(3):e264-e274. doi: 10.1212/WNL.0000000000201389. Epub 2022 Sep 29. Neurology. 2023. PMID: 36175151
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status.
Bun S, Ito D, Tezuka T, Kubota M, Ueda R, Takahata K, Moriguchi S, Kurose S, Momota Y, Suzuki N, Morimoto A, Hoshino Y, Seki M, Mimura Y, Shikimoto R, Yamamoto Y, Hoshino T, Sato Y, Tabuchi H, Mimura M. Bun S, et al. Among authors: yamamoto y. Alzheimers Res Ther. 2023 Sep 4;15(1):149. doi: 10.1186/s13195-023-01296-5. Alzheimers Res Ther. 2023. PMID: 37667408 Free PMC article.
Association between mammillary body atrophy and memory impairment in retired athletes with a history of repetitive mild traumatic brain injury.
Miyata M, Takahata K, Sano Y, Yamamoto Y, Kurose S, Kubota M, Endo H, Matsuoka K, Tagai K, Oya M, Hirata K, Saito F, Mimura M, Kamagata K, Aoki S, Higuchi M. Miyata M, et al. Among authors: yamamoto y. Sci Rep. 2024 Mar 26;14(1):7129. doi: 10.1038/s41598-024-57383-6. Sci Rep. 2024. PMID: 38531908 Free PMC article.
[(3)The Elderly, Dementia and Automobile Driving].
Yamamoto Y, Mimura M. Yamamoto Y, et al. No Shinkei Geka. 2020 Oct;48(10):973-978. doi: 10.11477/mf.1436204305. No Shinkei Geka. 2020. PMID: 33071236 Japanese. No abstract available.
11,991 results
You have reached the last available page of results. Please see the User Guide for more information.